Cardiologs
Cardiologs, a Philips subsidiary based in Paris, develops the first FDA-cleared deep learning-powered ECG analysis platform for arrhythmia detection and Holter monitoring, serving hospitals, cardiology clinics, and diagnostic service providers globally through Philips' healthcare distribution channel.
- Company typePrivate
- Founded2014
- HeadquartersParis, France
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Cardiologs does
Cardiologs is a Paris-based medical AI company that builds deep learning-powered software for the analysis of electrocardiogram (ECG) data, with a focus on arrhythmia detection and Holter monitoring. Founded in 2014, the company developed the Cardiologs Holter Platform, which became the first FDA-cleared ECG analysis solution powered by deep learning technology. The platform processes over 200 million ECGs and supports diagnosis of more than two million patients per year, offering clinicians and diagnostic service providers a cloud-based tool to reduce the manual burden of ECG interpretation and accelerate cardiac diagnosis. The underlying technology combines clinically validated deep learning algorithms with cloud infrastructure, protected by four patents and validated through more than 20 peer-reviewed publications and abstracts.
The company serves two primary customer segments: healthcare institutions and cardiology clinics requiring ECG analysis and arrhythmia diagnostic support, and diagnostic service providers managing high volumes of remote cardiac monitoring and population health screening. The go-to-market motion is enterprise-focused, with quote-based annual subscription licensing for the software as a medical device. Since being acquired by Koninklijke Philips N.V., Cardiologs operates as a wholly-owned subsidiary within Philips Healthcare's ambulatory monitoring and diagnostics division, with the product distributed exclusively through Philips' global healthcare sales channel. This integration provides Cardiologs with global institutional reach, regulatory infrastructure, and brand credibility in the medical device market that would have been difficult to build independently. The leadership team includes co-founder and CEO Yann Fleureau, co-founder and CSO Jia Li, COO Nicolas Godin, CCO Motty Klots, and CTO Romain Pomier.
Cardiologs firmographics
Firmographics- Name
- Cardiologs
- Legal name
- Cardiologs
- Website
- https://cardiologs.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Cardiologs, a Philips subsidiary based in Paris, develops the first FDA-cleared deep learning-powered ECG analysis platform for arrhythmia detection and Holter monitoring, serving hospitals, cardiology clinics, and diagnostic service providers globally through Philips' healthcare distribution channel.
- Ownership category
- akta.pro rank
Cardiologs industry classification
Industry- Product category
- Cardiac Diagnostics Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- Cardiology Telemedicine Platforms (HLALAGAB), General Cardiology (Consultative) (HLAKABAA)
Keywords
Where Cardiologs is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Markets served
Cardiologs business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- ECG Analysis Software Licensing: Cardiologs provides AI-powered ECG analysis software as a medical device solution. The platform is distributed through Philips' healthcare channel as a professional healthcare tool, likely sold as a subscription or license to healthcare institutions and cardiology service providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise healthcare licensing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Cardiologs product offering
Product offeringCore offering
Cardiologs provides an AI-powered, FDA-cleared Holter ECG analysis platform that uses deep learning algorithms to detect arrhythmias and assist clinicians with cardiac diagnostics. The cloud-based software is sold to hospitals, cardiology clinics, and diagnostic service providers through Philips' healthcare distribution channel, helping reduce the burden of manual ECG interpretation and enabling faster, more scalable cardiology diagnoses.
Product overview
Cardiologs, a Philips company, offers a unified ECG analysis platform centered on its FDA-cleared Cardiologs Holter Platform. The solution utilizes clinically validated deep learning AI to help reduce the burden of ECG analysis, making cardiology diagnostics scalable and accessible. The platform processes over 200 million ECGs and helps diagnose over two million patients per year, providing tools for clinicians and service providers globally.
Differentiator
Problem solved
Functional benefit
Products and services
- Cardiologs Holter Platform The first FDA-cleared ECG analysis solution powered by deep learning technology. It helps clinicians diagnose arrhythmias by analyzing Holter ECG data with AI, reducing the burden of ECG analysis and enabling faster diagnoses for hospitals, cardiology clinics, and diagnostic service providers.
Quantifiable outcome
- Tripled Holter activity within 2 years at ICPS using Cardiologs Holter
- +2 more outcomes
Companies that use Cardiologs
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Cardiologs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature3 records
Cardiologs partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PhilipscorePhilips acquired Cardiologs and operates it as a subsidiary brand within their healthcare division. Cardiologs ECG analysis software is sold and distributed through Philips' ambulatory monitoring and diagnostics portfolio, leveraging Philips' global healthcare distribution network, regulatory expertise, and brand credibility in medical devices.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
Cardiologs competitors and assessment
Company assessmentDirect peers
- iRhythm Technologies: Public US company behind the Zio patch ambulatory cardiac monitor, which combines a wearable patch with a cloud-based AI ECG analytics platform. Direct competitor to Cardiologs in AI-driven ambulatory arrhythmia detection, serving cardiology clinics and hospitals with a device-plus-software model.
- AliveCor: AI-ECG company offering KardiaMobile consumer/clinical single-lead ECG devices and KardiaPro cloud platform for arrhythmia detection. Directly comparable to Cardiologs in deploying deep-learning ECG algorithms for arrhythmia screening and remote cardiac monitoring.
- Eko Health: Maker of AI-enabled digital stethoscopes and handheld ECGs (CORE 500) with FDA-cleared AI algorithms for cardiac murmur and AFib detection. Comparable to Cardiologs through deep-learning ECG/sound analysis for arrhythmia and cardiac disease screening in clinical settings.
- Preventice Solutions (Boston Scientific): Acquired by Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring with AI-assisted ECG analysis. Direct competitor in ambulatory cardiac monitoring with cloud-based arrhythmia detection for hospitals and cardiology practices.
- Bardy Diagnostics (Baxter): Acquired by Baxter, Bardy offers the Carnation Ambulatory Monitor (CAM) patch with cloud ECG analysis. Comparable to Cardiologs in ambulatory ECG capture paired with algorithmic arrhythmia interpretation for clinical diagnostics.
Broad incumbents
- GE HealthCare: Large incumbent medical device and diagnostics company offering MUSE cardiology ECG management systems and broader cardiac care portfolio. Comparable as a broad incumbent embedding ECG management and increasingly AI-driven analysis into hospital workflows.
- Siemens Healthineers: Global medtech incumbent with a cardiology portfolio spanning ECG, cardiac imaging, and diagnostic AI. Comparable as a broad incumbent competing for hospital cardiology IT and ECG analytics budgets alongside specialty AI-ECG vendors like Cardiologs.
Emerging players
- HeartFlow: AI-driven non-invasive cardiac diagnostics company using CT-derived FFR analysis for coronary disease. Comparable as an emerging AI-cardiology diagnostics vendor targeting the same cardiology enterprise buyer, though focused on imaging rather than ECG.
- Cardiac Insight: Developer of the Cardea Solo wearable ECG sensor and associated AI-based arrhythmia analysis platform. Comparable as a smaller emerging player in ambulatory ECG + AI analytics competing for cardiology clinic adoption.
- QT Medical: Compact 12-lead ECG (PCA 500) with cloud platform and AI-assisted interpretation, targeting both clinical and consumer/remote use. Comparable as an emerging AI-ECG vendor pairing a device with cloud analytics for distributed cardiac monitoring.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Cardiologs social profiles
Digital presenceCardiologs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cardiologs leadership team
Management profileNumber of profiles
Profiles5 records
Cardiologs funding detail
Funding detailFunding overview
Funding rounds5 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cardiologs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cardiologs
What does Cardiologs do?
Cardiologs provides an AI-powered, FDA-cleared Holter ECG analysis platform that uses deep learning algorithms to detect arrhythmias and assist clinicians with cardiac diagnostics. The cloud-based software is sold to hospitals, cardiology clinics, and diagnostic service providers through Philips' healthcare distribution channel, helping reduce the burden of manual ECG interpretation and enabling faster, more scalable cardiology diagnoses.
Is Cardiologs a public or private company?
Cardiologs is a private company. It is classified as corporate owned and is currently operating.
When was Cardiologs founded?
Cardiologs was founded in 2014. It employs 51 to 100 people.
Where is Cardiologs based?
Cardiologs is headquartered in Paris, France, in the Europe region.
How does Cardiologs make money?
One revenue line is on record: ECG Analysis Software Licensing.
Who are Cardiologs's main competitors?
Direct peers on record are iRhythm Technologies, AliveCor, Eko Health, Preventice Solutions (Boston Scientific) and Bardy Diagnostics (Baxter). Broad incumbents are GE HealthCare and Siemens Healthineers. Emerging players are HeartFlow, Cardiac Insight and QT Medical.
Does Cardiologs have an API?
No public API is recorded for Cardiologs.
What industry is Cardiologs in?
Cardiologs's product category is Cardiac Diagnostics Software. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 513210 and its SIC code is 7372.